The week in industry: Citizen Petition filled for FDA to revoke orphan designation for SUBLOCADE™
This week: Aldery Park to transfer imagining services to Medicines Discovery Catapult (both Macclesfield, UK), the US FDA approves treatment of osteoporosis in postmenopausal women and Appili Therapeutics (NS, Canada) to receive financial support from the Canadian government to develop of novel anti-infective drugs.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>